Oral Corticosteroid Relieves Post-COVID-19 Anosmia in a 35-Year-Old Patient
Sam K. Touisserkani, Azin Ayatollahi
Abstract
Coronavirus disease 2019 (COVID-19) is a highly infectious respiratory illness caused by SARS-CoV-2. Not much is yet known about this new viral disease. In our early encounter with the COVID-19, before the pandemic and during the early days of dealing with this novel viral disease in our country, we saw some cases of anosmia in patients infected by SARS-CoV-2. In many cases, this chemosensitive dysfunction persisted after the negativization of the nasopharyngeal swab. We report effective treatment of anosmia by oral corticosteroid therapy in a patient recovered from COVID-19.
Topics & Concepts
AnosmiaMedicineCoronavirus disease 2019 (COVID-19)PandemicCorticosteroidSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Disease2019-20 coronavirus outbreakInfectious disease (medical specialty)Intensive care medicineVirologyInternal medicineOutbreakOlfactory and Sensory Function StudiesNeuroinflammation and Neurodegeneration MechanismsBiochemical Analysis and Sensing Techniques